Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Leases (2019 - 2026)

Bio-Techne has reported Current Leases over the past 7 years, most recently at $13.7 million for Q4 2025.

  • For Q4 2025, Current Leases rose 1.47% year-over-year to $13.7 million; the TTM value through Dec 2025 reached $13.7 million, up 1.47%, while the annual FY2025 figure was $14.1 million, 9.12% up from the prior year.
  • Current Leases for Q4 2025 was $13.7 million at Bio-Techne, roughly flat from $13.8 million in the prior quarter.
  • Over five years, Current Leases peaked at $14.1 million in Q2 2025 and troughed at $10.4 million in Q1 2021.
  • A 5-year average of $12.4 million and a median of $12.2 million in 2022 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: grew 23.79% in 2021 and later fell 9.62% in 2023.
  • Year by year, Current Leases stood at $11.8 million in 2021, then fell by 7.06% to $11.0 million in 2022, then grew by 15.46% to $12.7 million in 2023, then rose by 6.62% to $13.5 million in 2024, then rose by 1.47% to $13.7 million in 2025.
  • Business Quant data shows Current Leases for TECH at $13.7 million in Q4 2025, $13.8 million in Q3 2025, and $14.1 million in Q2 2025.